Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
ONSIW was delisted on the 3rd of December, 2018.
5 hedge funds and large institutions have $30K invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
44% less funds holding
Funds holding: 9 → 5 (-4)
77% less capital invested
Capital invested by funds: $130K → $30K (-$100K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$12K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$4.64K |
| 3 |
VF
Virtu Financial
New York
|
-$4K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $13K | – | – | – |
|
|
ACA
2
Avoro Capital Advisors
New York
| $7K | – | – | – |
|
|
MWNA
3
Marshall Wace North America
New York
| $4K | – | – | – |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| $3K | -$4.64K | -68,651 | -43% |
|
|
PC
5
PointState Capital
New York
| $2K | – | – | – |
|
|
MIM
6
Monashee Investment Management
Boston,
Massachusetts
| $1K | – | – | – |
|
|
ACP
7
Acuta Capital Partners
Redwood City,
California
| – | -$12K | -96,833 | Closed |
|
|
VF
8
Virtu Financial
New York
| – | -$4K | -33,928 | Closed |
|
|
TSS
9
Two Sigma Securities
New York
| – | -$1K | -11,141 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$1K | -7,888 | Closed |
|
ONSIW Hedge Fund Activity: Q4 2017 in Review
5 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q4 2017, worth a combined $30K — down 77% from $130K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ONSIW and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Acuta Capital Partners, exiting entirely with an estimated $12K sold.
- 5 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q4 2017, down from 9 in Q3 2017.
- Funds reported $30K of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q4 2017, down 77% quarter-over-quarter.
- 0 funds opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q4 2017 and 4 closed out, a net change of -4 holders.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q4 2017 was Acuta Capital Partners, an estimated $12K sold.
Based on aggregated 13F filings for Q4 2017.